Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

9,114 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A multicenter retrospective study aiming to identify patients who respond well to adsorptive granulomonocytapheresis in moderately to severely active ulcerative colitis.
Yamamoto T, Iida T, Ikeya K, Kato M, Matsuura A, Tamura S, Takano R, Tani S, Osawa S, Sugimoto K, Shimoyama T, Hanai H. Yamamoto T, et al. Among authors: kato m. Clin Transl Gastroenterol. 2018 Jul 6;9(7):170. doi: 10.1038/s41424-018-0037-0. Clin Transl Gastroenterol. 2018. PMID: 29977035 Free PMC article.
Correction: A multicenter retrospective study aiming to identify patients who respond well to adsorptive granulomonocytapheresis in moderately to severely active ulcerative colitis.
Yamamoto T, Iida T, Ikeya K, Kato M, Matsuura A, Tamura S, Takano R, Tani S, Osawa S, Sugimoto K, Shimoyama T, Hanai H. Yamamoto T, et al. Among authors: kato m. Clin Transl Gastroenterol. 2018 Oct 8;9(10):192. doi: 10.1038/s41424-018-0062-z. Clin Transl Gastroenterol. 2018. PMID: 30310050 Free PMC article.
Correction: A multicenter retrospective study aiming to identify patients who respond well to adsorptive granulomonocytapheresis in moderately to severely active ulcerative colitis.
Yamamoto T, Iida T, Ikeya K, Kato M, Matsuura A, Tamura S, Takano R, Tani S, Osawa S, Sugimoto K, Shimoyama T, Hanai H. Yamamoto T, et al. Among authors: kato m. Clin Transl Gastroenterol. 2018 Nov 14;9(11):205. doi: 10.1038/s41424-018-0073-9. Clin Transl Gastroenterol. 2018. PMID: 30429462 Free PMC article.
Highly Bioavailable Curcumin Derivative Ameliorates Crohn's Disease Symptoms: A Randomized, Double-Blind, Multicenter Study.
Sugimoto K, Ikeya K, Bamba S, Andoh A, Yamasaki H, Mitsuyama K, Nasuno M, Tanaka H, Matsuura A, Kato M, Ishida N, Tamura S, Takano R, Tani S, Osawa S, Nishihira J, Hanai H. Sugimoto K, et al. Among authors: kato m. J Crohns Colitis. 2020 Dec 2;14(12):1693-1701. doi: 10.1093/ecco-jcc/jjaa097. J Crohns Colitis. 2020. PMID: 32412598 Clinical Trial.
Global modified Delphi consensus on diagnosis, phenotypes, and treatment of SCN8A-related epilepsy and/or neurodevelopmental disorders.
Conecker G, Xia MY, Hecker J, Achkar C, Cukiert C, Devries S, Donner E, Fitzgerald MP, Gardella E, Hammer M, Hegde A, Hu C, Kato M, Luo T, Schreiber JM, Wang Y, Kooistra T, Oudin M, Waldrop K, Youngquist JT, Zhang D, Wirrell E, Perry MS. Conecker G, et al. Among authors: kato m. Epilepsia. 2024 May 27. doi: 10.1111/epi.17992. Online ahead of print. Epilepsia. 2024. PMID: 38802994
Global modified-Delphi consensus on comorbidities and prognosis of SCN8A-related epilepsy and/or neurodevelopmental disorders.
Conecker G, Xia MY, Hecker J, Achkar C, Cukiert C, Devries S, Donner E, Fitzgerald M, Gardella E, Hammer M, Hegde A, Hu C, Kato M, Luo T, Schreiber JM, Wang Y, Kooistra T, Oudin M, Waldrop K, Youngquist JT, Zhang D, Wirrell E, Perry MS. Conecker G, et al. Among authors: kato m. Epilepsia. 2024 May 27. doi: 10.1111/epi.17991. Online ahead of print. Epilepsia. 2024. PMID: 38802989
9,114 results